Paasa Logo
CollPlant Biotechnologies Ltd. logo
CLGNNASDAQMarket openCloses 4:00pm ET

CollPlant Biotechnologies Ltd.

$4.22Last updated
+$0.10 (2.31%)Past day
Timezone

CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) is trading at $4.22, about ₹405 at today's USD/INR rate, as of 25 Sep 2026, 9:48 AM ET, up 2.31% today. Indian residents can buy CollPlant Biotechnologies from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$4.10
Previous close:$4.12
Volume:3.35K

Today's low

$4.10

Today's high

$4.29

52 week low

$2.64

52 week high

$31.80

CLGN opened at $4.10, closed previously at $4.12, and has traded between $2.64 and $31.80 over the past 52 weeks.

About

CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine enterprise operating across the United States, Canada, and Europe. The company primarily engages in the three-dimensional (3D) bioprinting of tissues and organs, alongside developing solutions for medical aesthetics. All of CollPlant's offerings are underpinned by its proprietary plant-based genetic engineering technology, which facilitates the production of recombinant type I human collagen. Its diverse product portfolio encompasses BioInks engineered for 3D tissue and organ fabrication; dermal and soft tissue fillers designed to diminish wrinkles; and innovative breast implants, both 3D bioprinted and injectable, aimed at promoting breast tissue regeneration. CollPlant also provides a 3D bioprinted regenerative soft tissue matrix. Specialized products include VergenixSTR, a soft tissue repair matrix targeting tendinopathy, and VergenixFG, an advanced wound care treatment for deep surgical incisions and persistent wounds such as diabetic, venous, and pressure ulcers, burns, and bedsores. The company maintains strategic collaboration agreements with numerous partners, including 3D Systems Corporation, CellInk (a BICO Group company), the Advanced Regenerative Manufacturing Institute, the RegenMed Development Organization, Israel's Technion Institute of Technology, AbbVie, and STEMCELL. Established in Rehovot, Israel, in 2004, the company was formerly known as CollPlant Holdings Ltd. before adopting its current name in June 2019.

Country
IL
CEO
Yehiel Tal
Exchange listed on
NASDAQ
Industry
Biotechnology
Base currency
USD
Full Time Employees
39
Sector
Healthcare
IPO date
31/01/2018

Key statistics

Avg. volume

242.16K

Market cap

$5.47M

P/E Ratio

-0.41

Price-to-sales ratio

14.05

Enterprise value

$3.85M

Free cash flow yield

-212.28%

Debt-to-equity ratio

0.54

Return on equity

-160.28%

ROIC

-171.86%

Beta

0.74

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$2.37M

Earnings per share

-$9.40

Free cash flow

-$9.45M

Net profit margin

-3376.35%

Gross margin

-319.28%

EBITDA

-$10.56M

Revenue growth

360.39%

Similar securities

This is not an investment recommendation

How to buy CollPlant Biotechnologies from India

Indian residents can buy CollPlant Biotechnologies shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for CollPlant Biotechnologies and place an order

    Find CollPlant Biotechnologies by name or by its ticker, CLGN, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. CollPlant Biotechnologies trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your CollPlant Biotechnologies position in USD and INR. CollPlant Biotechnologies pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in CollPlant Biotechnologies from India

Trading and taxes when buying CollPlant Biotechnologies from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneCollPlant Biotechnologies does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy CollPlant Biotechnologies stock?

Yes. CollPlant Biotechnologies (CLGN) has been listed on NASDAQ since 2018, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one CollPlant Biotechnologies share cost in rupees?

One CollPlant Biotechnologies share is $4.22 — about ₹405 at a USD/INR rate of 96.02 on 24 Sep 2026. Both the CollPlant Biotechnologies price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying CollPlant Biotechnologies from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of CollPlant Biotechnologies?

Yes. One CollPlant Biotechnologies share is $4.22, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in CollPlant Biotechnologies.

How are gains on CollPlant Biotechnologies shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the CollPlant Biotechnologies price. Paasa issues a capital-gains statement for your return.

Does CollPlant Biotechnologies pay a dividend?

No. CollPlant Biotechnologies does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade CollPlant Biotechnologies from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is CollPlant Biotechnologies a United States company, and does that change how it is taxed?

CollPlant Biotechnologies trades on NASDAQ in US dollars, but the company is domiciled in Israel. CollPlant Biotechnologies trades as an American Depositary Receipt rather than an ordinary share. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.

Do I have to declare CollPlant Biotechnologies shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your CollPlant Biotechnologies holding, its cost and its closing value.

How do I sell CollPlant Biotechnologies and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.